Dermata Therapeutics, Inc. (DRMA) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.24
Day's range
$1.33

Dermata Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 48.33 K $58.48 K   100.00% 1.25%
UBS GROUP AG 05/05/2026 35.61 K $43.09 K   2,778.58% 0.92%
WELCH & FORBES LLC 05/01/2026 20.00 K $24.20 K   100.00% 0.52%
MCF ADVISORS LLC 05/11/2026 1.73 K $2.10 K   100.00% 0.04%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2026 716 $866   -64.18% 0.02%
SBI SECURITIES CO., LTD. 04/28/2026 101 $122   0.00% 0.00%
CITIGROUP INC 05/11/2026 1 $1   100.00% 0.00%
JPMORGAN CHASE & CO 05/13/2026 0 $0   -100.00% 0.00%
BANK OF AMERICA CORP /DE/ 05/18/2026 0 $0   -100.00% 0.00%
BARCLAYS PLC 05/15/2026 0 $0   -100.00% 0.00%
CLEAR STREET GROUP INC. 05/15/2026 0 $0   -100.00% 0.00%

Dermata Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 11 institutional investors and hedge funds held shares of Dermata Therapeutics Inc. The most heavily invested institutionals were:

GEODE CAPITAL MANAGEMENT, LLC: 48,334

UBS Group AG: 35,608

WELCH & FORBES LLC: 20,000

MCF Advisors LLC: 1,732

Tower Research Capital LLC (TRC): 716

SBI Securities Co., Ltd.: 101

2.76% of Dermata Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 106.49 K shares in the last 24 months. This purchase volume represents approximately $141.63 K in transactions.